Patients Related Content

Prof. Andrew Boulton, MD, DSc (Hon), FACP, FICP, FRCP, President of the International Diabetes Federation, highlights why COVID-19 is a particular concern for people living with diabetes.

Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.

Tomoaki Kojima, CEO of Sourcenext Europe, explains how UK healthcare providers can overcome language barriers to help improve clinical outcomes for patients who don’t speak English as their first language.

e-Learning for Healthcare introduces the online programme of learning called e-Pain, and how it can directly benefit the NHS workforce, the wider NHS and its patients.

Director of Product Management at Bioquell, Guy Turner, explains how RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, thus providing a 6-log sporicidal kill and eliminating all traces of COVID-19.

Elena Posth & Romina Männl from Pfalzklinikum walk us through exactly how the company has entered into a new and exciting era of treating people with mental illness by charting their ‘Innovative psychiatry for the 21st century – Close to domicile. Competent. Human’ project.

New research has found that one in ten COVID-19 patients with diabetes dies within seven days of hospital admission.

Dr Juliana Bowles, School of Computer Science, University of St Andrews, discusses how to tackle polypharmacy and multimorbidities with computational techniques.

Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.

The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.

Johnathan Bulmer, MD at Cleveland Containers, explains how shipping containers are supporting capacity efforts during coronavirus.

Stuart Snape, Managing Partner, Graham Coffey & Co. Solicitors, walks us through what the COVID-19 pandemic has taught us about the need for urgent sepsis care.

Skin conditions often get worse when we are stressed – for example, during the COVID-19 pandemic. Have you just been diagnosed with acne rosacea? Are there any tips or tricks on how to manage it? Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explains everything you need to know.

Prof Monica Di Luca, President, European Brain Council, highlights the importance of continuous prioritisation and attention to brain research during the COVID-19 pandemic.

Neil Ballinger, head of EMEA sales at EU Automation, explains how greater access to quality healthcare can come from medical data and AI.

Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.

Innovative technologies have the power to entirely transform the NHS, mitigating the workforce challenges that it faces and transforming the patient experience, whilst improving outcomes, Justin Hall, Vice President and General Manager at iRhythm, discusses here.

Bethany Morris explores the consequences of failures in healthcare tech, from vulnerable key workers to limiting COVID-19 infection.

Prof Dr Freimut Schliess, Director of Profil GmbH, discusses how CROs can play a key role for the optimisation of innovation pathways.

Here, Dr Albert A. de Graaf discusses a novel predictive model-based decision support system to aid diabetes patients in the complex task of self-management.